Pediatric Study Plans Should Be Made Public, FDA’s Oncology Advisers Say

 
• By Sarah Karlin-Smith
  
young boy in hospital holding teddy bear and IV pole
The cancer research community needs more visibility into FDA-required pediatric study plans, agency advisors said. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D